Fielmann: Growth Ambitions Until 2030 - Expansion in Europe and the USA as Well as the Teleophthalmology Platform are set to Improve Revenue by 60%!
Reading Time: 1 minute
Among the high-quality companies, the stock of Fielmann (WKN 577220) is particularly interesting, being only 0.8% away from its 52-week high. Traders are watching for a potential breakout to the 52-week high! In the first half of the year, revenue grew by 12% to €1.2 billion. EBITDA increased by 26% to €290 million, which improved the margin from 21.1% to 23.7%. Fielmann attributed this to an improved sales structure, productivity gains, and cost efficiency. By 2030, the company has ambitious targets. Revenue is expected to increase from...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
